Category Archives: antiretroviral therapy

  1. Challenges for HIV Pre-Exposure Prophylaxis among Men Who Have Sex with Men in the United States

    via PLoS Medicine, by Gordon Mansergh, Beryl A. Koblin, Patrick S. Sullivan Summary Points: Pre-exposure prophylaxis (PrEP) with anti-retroviral (ARV) medications is partially efficacious for preventing HIV infection among men who have sex with men (MSM) and heterosexuals. As PrEP becomes available and prescribed for use among MSM a better understanding of willingness to use PrEP and Read More >>

    antiretroviral therapy, ARV, condoms, heterosexuality, HIV, hiv prevention, HIV transmission, HIV/AIDS, MSM, pre-exposure prophylaxis, PrEP
  2. Sustainable HIV prevention possibilities present choices, challenges

    via Science Speaks, by Antigone Barton When he looks at what biomedical science can do in the next decade to prevent HIV transmission, Jim Turpin of the National Institutes of Health said, he thinks of the lyrics of a Timbuk3 song: “The future’s so bright I gotta wear shades.” By, which, actually, he means — don’t get Read More >>

    antiretroviral therapy, AVAC, HIV, hiv prevention, HIV transmission, HIV/AIDS, IRMA, Microbicides, rectal microbicide, vaccine
  3. What kind of prevention do gay men need?

     via aidsmap, by Gus Cairns How do we stop the hyperepidemic in gay men? A number of presentations at the 19th International AIDS Conference explored the ‘hyperepidemic’ of HIV amongst men who have sex with men, and especially black MSM. A paper presented by Gregorio Millet (pictured above at a White House reception honoring people working in AIDS) showed that, at Read More >>

    AIDS 2012, anal sex, antiretroviral therapy, ARVs, gay men, HIV, hiv prevention, HIV transmission, HIV/AIDS, International AIDS Conference, MSM, pre-exposure prophylaxis, PrEP, Treatment as Prevention
  4. Interim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults

    via Morbidity and Mortality Weekly Report In the United States, an estimated 48,100 new human immunodeficiency virus (HIV) infections occurred in 2009 (1). Of these, 27% were in heterosexual men and women who did not inject drugs, and 64% were in men who have sex with men (MSM), including 3% in MSM who inject drugs. In January Read More >>

    antiretroviral therapy, ARVs, CDC, FDA, Gilead, heterosexuality, HIV, hiv prevention, HIV transmission, HIV/AIDS, iPrEx, MSM, PrEP, risk, Tenofovir, Truvada
  5. Rectal microbicide research gives hope for HIV protection

    via Citizens News Service, by Somya Arora According to the Microbicides Trials Network (MTN), HIV continues to disproportionately affect racial minorities and men who have sex with men (MSM). MTN estimates that 5 to 10 percent of the world’s population engages in anal sex and globally, MSM are 19 times more likely to be infected with HIV Read More >>

    AIDS Foundation of Chicago, anal sex, antiretroviral therapy, CHARM, Dr. Ian McGowan, HIV, HIV transmission, HIV/AIDS, IRMA, Jim Pickett, Microbicide Trials Network, MSM, MTN, rectal microbicide, STI
  6. Characteristics Qualifying Gay Men for Intermittent PrEP

    via, by Michael Carter Older, better-educated gay men who use sexual networking sites and have sex outside the context of committed relationships may be appropriate targets for intermittent pre-exposure prophylaxis (PrEP), US research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes suggests. The investigators found that individuals with this profile were Read More >>

    anal intercourse, antiretroviral therapy, gay men, HIV, hiv prevention, iPrEx, MSM, PrEP
  7. Antiretroviral Prophylaxis for HIV Prevention Reaches a Key Milestone

    via, by Salim S Abdool Karim  and Quarraisha Abdool Karim On May 10, 2012, a US Food and Drug Administration (FDA) advisory committee voted in support of the use of tenofovir-emtricitabine for HIV prevention.1 If the FDA, which is scheduled to make its decision by June 15, adopts the committee’s recommendations, tenofovir-emtricitabine will become the first Read More >>

    antiretroviral therapy, ART, ARV, ARVs, FDA, FEM-PrEP, HIV, HIV/AIDS. pre-exposure prophylaxis, pre-exposure prophylaxis, PrEP, Salim S. Abdool Karim, Treatment, Treatment as Prevention, VOICE
  8. Fenway Releases PrEP Policy Paper

    viaFenway Health Pre-exposure chemoprophylaxis (PrEP)—taking antiretroviral medications to prevent HIV transmission—could be a “game changer” for HIV prevention. PrEP has demonstrated partial efficacy with men who have sex with men (MSM), transgender women, and heterosexuals in several recent studies. Recent modeling of PrEP implementation coupled with scaled up treatment predicts that PrEP could significantly reduce HIV incidence Read More >>

    antiretroviral therapy, ARV, Fenway community healthhiv prevention, HIV/AIDS. pre-exposure prophylaxis, MSM, pre-exposure prophylaxis, PrEP
  9. Plasma and rectal viral load correlated in HIV-positive gay men: supports use of treatment as prevention

    via European AIDS Treatment Group, by Michael Carter Viral load in the blood and rectal secretions of HIV-positive gay men are highly correlated, according to US research published in the September 1st edition of the Journal of Infectious Diseases. The study also showed that the presence of sexually transmitted infections did not increase rectal viral load. Individuals Read More >>

    antiretroviral therapy, HIV, MSM, rectal transmission, Treatment, Treatment as Prevention, viral load
  10. Early ARV Treatment Will Save Lives in South Africa

    Via All Africa. Government’s decision to offer free ARV treatment to people with CD4 counts of 350 or less has been welcomed as a life-saver. The South African government’s announcement that it will give antiretroviral medication to people with HIV who have CD4 counts of below 350 will save lives and prevent infection. This is according to Read More >>

    Africa, antiretroviral therapy, ARVs, HIV/AIDS policy, South Africa, Treatment, Treatment as Prevention